November 23, 2020

Letter to the Editor: Carney, Rubino Display Distinct Differences in Response to Trump, Understand Them and Make Your Choice

To the Editor:

In 2016, Devin Carney said of Donald Trump, “Up to this point I have not expressed support for him and have not endorsed him. I’m not supporting him. I’m not supporting Mrs. Clinton either.”  Of course, the polls favored Hillary Clinton at the time so the politically opportune thing for a Republican to do was to ride the fence. Don’t endorse, but don’t rebuke. Since that time, Donald Trump has been caught on video making vulgar comments about women, ignored a global pandemic so profoundly that the U.S. has seen more than 220,000 deaths, overseen the biggest recession since the depression, and sowed racial divisions like no other President in recent history. Even Fox News confirmed that he called our fallen veterans “losers” and “suckers.”  One would think that Carney has ample reason to pick a side now. But he hasn’t. Because disavowing the President will lose him votes. We need a leader who has the courage to take a position on the important issues of the day – even if it will cost him politically.

Dave Rubino has rebuked President Trump from the get-go. When Trump pushed the myth that absentee ballots would lead to fraud, Dave pushed back with the facts. Voters in our district should not have to choose between their health and their Constitutional rights. When Trump said that states like Connecticut had to send their students back to school or lose Federal funding, Dave spoke out. Most significantly, when in the wake of George Floyd’s murder, the political tides favored support of Black Lives Matter, Carney spoke with vigor at BLM rallies. But when Trump and his enablers came out against police accountability, Devin fell in line and voted against the police accountability act.

We deserve better than that. We deserve a leader who will stand for what’s right regardless of the political consequences. We deserve Dave Rubino.

Sincerely,

Kim Thompson,
Old Lyme.

Share